Binding of p53 to the Central Domain of Mdm2 Is Regulated by Phosphorylation
Open accessThe DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
The Mdm2 protein is the major regulator of the tumor suppressor protein p53. We show that the p53 protein associates both with the N-terminal and with the central domain of Mdm2. The central p53-binding site of Mdm2 encompasses amino acids 235–300. Binding of p53 to the central domain is significantly enhanced after phosphorylation of the central domain of Mdm2. The N-terminal and central domains of Mdm2 act synergistically in binding to p53. p53 mutants that have mutations in the tetramerization domain and that fail to oligomerize do not show such an enhancement of binding in the presence of the other binding site. The Mdm2 protein is the major regulator of the tumor suppressor protein p53. We show that the p53 protein associates both with the N-terminal and with the central domain of Mdm2. The central p53-binding site of Mdm2 encompasses amino acids 235–300. Binding of p53 to the central domain is significantly enhanced after phosphorylation of the central domain of Mdm2. The N-terminal and central domains of Mdm2 act synergistically in binding to p53. p53 mutants that have mutations in the tetramerization domain and that fail to oligomerize do not show such an enhancement of binding in the presence of the other binding site. One of the major functions of the Mdm2 protein is to control abundance and activity of the tumor suppressor protein p53. This activity requires direct interaction between p53 and Mdm2 (1Haupt Y. Maya R. Kazaz A. Oren M. Nature. 1997; 387: 296-299Crossref PubMed Scopus (3790) Google Scholar) that is brought about by the N-terminal domains of both proteins (2Kussie P.H. Gorina S. Marechal V. Elenbaas B. Moreau J. Levine A.J. Pavletich N.P. Science. 1996; 274: 948-953Crossref PubMed Scopus (1845) Google Scholar). This interaction prevents p53 from activating its target genes and allows Mdm2-mediated polyubiquitylation and degradation of p53 (reviewed in Ref. 3Iwakuma T. Lozano G. Mol. Cancer Res. 2003; 1: 993-1000PubMed Google Scholar). The importance of this interaction has been supported convincingly by in vivo experiments. Mice lacking Mdm2 die before implantation. They will, however, survive by concomitant deletion of p53 (4Jones S.N. Roe A.E. Donehower L.A. Bradley A. Nature. 1995; 378: 206-208Crossref PubMed Scopus (1078) Google Scholar, 5Montes de Oca Luna R. Wagner S.D. Lozano G. Nature. 1995; 378: 203-206Crossref PubMed Scopus (1217) Google Scholar). The p53-binding pocket of Mdm2 comprises the first 100 amino acids of Mdm2. Other motifs of Mdm2 include a Ring finger (aa 450–480), 2The abbreviations used are: aa, amino acid(s); PBS, phosphate-buffered saline; wt, wild type; GST, glutathione S-transferase; PCNA, proliferating nuclear cell antigen; HRP, horseradish peroxidase. a nuclear localization signal (aa 160–180), a nuclear export signal (aa 180–195), a nucleolar localization signal (aa 464–471), and a central acidic domain (aa 200–300) (6Freedman D.A. Levine A.J. Mol. Cell Biol. 1998; 18: 7288-7293Crossref PubMed Scopus (462) Google Scholar, 7Lohrum M.A. Ashcroft M. Kubbutat M.H. Vousden K.H. Nat. Cell Biol. 2000; 2: 179-181Crossref PubMed Scopus (171) Google Scholar, 8Roth J. Dobbelstein M. Freedman D.A. Shank T. Levine A.J. EMBO J. 1998; 17: 554-564Crossref PubMed Scopus (536) Google Scholar). The central acidic domain of Mdm2 is necessary for the interaction with a number of proteins including p300, L11, and p19ARF (reviewed in Ref. 3Iwakuma T. Lozano G. Mol. Cancer Res. 2003; 1: 993-1000PubMed Google Scholar). Recently, this domain was found to contribute to p53 turnover. Mdm2 mutants with point mutations or deletions in the central domain may allow p53 ubiquitylation but prevent p53 degradation (9Argentini M. Barboule N. Wasylik B. Oncogene. 2001; 20: 1267-1275Crossref PubMed Scopus (71) Google Scholar, 10Blattner C. Hay T. Meek D. Lane D.P. Mol. Cell Biol. 2002; 22: 6170-6182Crossref PubMed Scopus (127) Google Scholar, 11Zhu Q. Yao J. Wani G. Wani M.A. Wani A.A. J. Biol. Chem. 2001; 276: 29695-29701Abstract Full Text Full Text PDF PubMed Scopus (48) Google Scholar). p53 and Mdm2 receive and integrate signals that monitor genome stability, replication state, and growth conditions. In response to these signals, the p53/Mdm2 system regulates transcription of genes whose products prevent cell cycle progression or induce programmed cell death (reviewed in Ref. 28Kohn K.W. Pommier Y. Biochem. Biophys. Res. Commun. 2005; 331: 816-827Crossref PubMed Scopus (93) Google Scholar). Transcriptional activity as well as degradation of p53 requires its assembly into tetramers, which is brought about by an oligomerization domain (aa 324–355) (Refs. 12Blattner C. Tobiasch E. Litfin M. Rahmsdorf H.J. Herrlich P. Oncogene. 1999; 18: 1723-1732Crossref PubMed Scopus (132) Google Scholar and 13Friedman P.N. Chen X. Bargonetti J. Prives C. Proc. Natl. Acad. Sci. U. S. A. 1993; 90: 3319-3323Crossref PubMed Scopus (226) Google Scholar; reviewed in Ref. 14Chene P. Oncogene. 2001; 20: 2611-2617
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Structure of the MDM2 Oncoprotein Bound to the p53 Tumor Suppressor Transactivation Domain
Kussie, P. H., Gorina, S., Marechal, V., Elenbaas, B., Moreau, J., Levine, A. J., & Pavletich, N. P. (1996) · Science · doi:10.1126/science.274.5289.948 · Cited by 2,206
Rescue of early embryonic lethality in mdm2-deficient mice by deletion of p53
de Oca Luna, R. M., Wagner, D. S., & Lozano, G. (1995) · Nature · doi:10.1038/378203a0 · Cited by 1,420
Rescue of embryonic lethality in Mdm2-deficient mice by absence of p53
Jones, S. N., Roe, A. E., Donehower, L. A., & Bradley, A. (1995) · Nature · doi:10.1038/378206a0 · Cited by 1,280
Association of p19ARF with Mdm2 inhibits ubiquitin ligase activity of Mdm2 for tumor suppressor p53
Honda, R., & Yasuda, H. (1999) · The EMBO Journal · doi:10.1093/emboj/18.1.22 · Cited by 724
MDM2–HDAC1-mediated deacetylation of p53 is required for its degradation
Ito, A., Kawaguchi, Y., Lai, C., Kovacs, J. J., Higashimoto, Y., Appella, E., & Yao, T. (2002) · The EMBO Journal · doi:10.1093/emboj/cdf616 · Cited by 570
Acetylation of p53 inhibits its ubiquitination by Mdm2
Li, M., Luo, J., Brooks, C. L., & Gu, W. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.c200578200 · Cited by 503
DNA damage induced p53 stabilization: no indication for an involvement of p53 phosphorylation
Blattner, C., Tobiasch, E., Litfen, M., Rahmsdorf, H. J., & Herrlich, P. (1999) · Oncogene · doi:10.1038/sj.onc.1202480 · Cited by 151
Self-citationHypophosphorylation of Mdm2 Augments p53 Stability
Blattner, C., Hay, T., Meek, D. W., & Lane, D. P. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.17.6170-6182.2002 · Cited by 144
Self-citationWinter, M., Milne, D., Dias, S., Kulikov, R., Knippschild, U., Blattner, C., & Meek, D. (2004) · Biochemistry · doi:10.1021/bi0489255 · Cited by 60
Cited by
Kruse, J.-P., & Gu, W. (2009) · Cell · doi:10.1016/j.cell.2009.04.050 · Cited by 1,610
Acetylation Is Indispensable for p53 Activation
Tang, Y., Zhao, W., Chen, Y., Zhao, Y., & Gu, W. (2008) · Cell · doi:10.1016/j.cell.2008.03.025 · Cited by 838
Tumour suppression by p53: a role for the DNA damage response?
Meek, D. W. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2716 · Cited by 609
Ubiquitin and ubiquitin-like proteins in cancer pathogenesis
Hoeller, D., Hecker, C.-M., & Dikic, I. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1994 · Cited by 408
Regulation of the p53 response and its relationship to cancer
Meek, D. W. (2015) · Biochemical Journal · doi:10.1042/bj20150517 · Cited by 288
Metadata
- Authors
- Kulikov, R., Winter, M., & Blattner, C.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2006-09
- Volume
- 281
- Issue
- 39
- Pages
- 28575-28583
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2080964628
- Cited by
- 79
- References
- 9
- FWCI
- 4.96
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Binding of p53 to the Central Domain of Mdm2 Is Regulated by Phosphorylation. https://app.cochat.ai/papers/10.1074/jbc.m513311200
- The paper
- Kulikov, R., Winter, M., & Blattner, C. (2006). Binding of p53 to the Central Domain of Mdm2 Is Regulated by Phosphorylation. Journal of Biological Chemistry. https://doi.org/10.1074/jbc.m513311200
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.